Stir Pharma
Home
Our Team
INVESTOR CONTACT
Stir Pharma
Home
Our Team
INVESTOR CONTACT
More
  • Home
  • Our Team
  • INVESTOR CONTACT
  • Home
  • Our Team
  • INVESTOR CONTACT

Our Team

Dr. Iona Weir, PhD

Dr. Timothy Meakin, BSc.HonPhys, MD (UBC), FRNZCGP

Dr. Selywn Yorke, PhD MInstD FNZIC

Board Chair

Chief Scientific Officer

Iona has an extensive background in pharmaceuticals, Over The Counter (OTC) and botanical drug development, and natural products including food, dietary supplements and skin treatment creams.  Iona has vast experience in new product development, clinical trials, patenting, regulatory requirements and man

Board Chair

Chief Scientific Officer

Iona has an extensive background in pharmaceuticals, Over The Counter (OTC) and botanical drug development, and natural products including food, dietary supplements and skin treatment creams.  Iona has vast experience in new product development, clinical trials, patenting, regulatory requirements and manufacturing. Iona has previously served as Executive Director and CSO at BioDiscovery NZ, CSO for Phloe (Vital Foods) and CSO and Executive Director for Meracol/Lypanosys opening the IND (Investigative New Drug) for a botanical drug for eczema with the USFDA. Iona founded her own company Weir Science (formerly Decima Health) which has developed and patented a USFDA OTC eczema treatment cream and now Myregyna which is in the FDA registration process as a medical device for urogenital post-menopause treatment. Iona is the CEO and executive director of Weir Science.

Dr. Selywn Yorke, PhD MInstD FNZIC

Dr. Timothy Meakin, BSc.HonPhys, MD (UBC), FRNZCGP

Dr. Selywn Yorke, PhD MInstD FNZIC

Director

Chief Technical Officer

Selywn has an extensive background in drug development, medical devices, natural products and related technology, product development, and manufacturing. He was the Business Development Manager at NZ Pharmaceuticals - a GMP certified manufacturer of drug substances and pharmaceutical intermediates. Selwyn is

Director

Chief Technical Officer

Selywn has an extensive background in drug development, medical devices, natural products and related technology, product development, and manufacturing. He was the Business Development Manager at NZ Pharmaceuticals - a GMP certified manufacturer of drug substances and pharmaceutical intermediates. Selwyn is a professional Director with two Chair and three other Board positions on start-up and tech organizations.

Dr. Timothy Meakin, BSc.HonPhys, MD (UBC), FRNZCGP

Dr. Timothy Meakin, BSc.HonPhys, MD (UBC), FRNZCGP

Dr. Timothy Meakin, BSc.HonPhys, MD (UBC), FRNZCGP

Director

Chief Medical Officer

Tim is a retired medical practitioner with a special interest in developing innovative medical treatments.  In Canada he founded "Vancouver Family Health Centre", Vancouver's first one stop centre for all health care needs. Tim co-founded Meracol Corp and was instrumental in the development of products for the

Director

Chief Medical Officer

Tim is a retired medical practitioner with a special interest in developing innovative medical treatments.  In Canada he founded "Vancouver Family Health Centre", Vancouver's first one stop centre for all health care needs. Tim co-founded Meracol Corp and was instrumental in the development of products for the treatment of Eczema and IBS.  His research led to the granting of numerous patents related to these products.

Richard Coon, ONZM, BA, MBA (Harvard), FCA

Dr. Timothy Meakin, BSc.HonPhys, MD (UBC), FRNZCGP

Dr. Timothy Meakin, BSc.HonPhys, MD (UBC), FRNZCGP

Director

Chief Financial Officer

Richard is a serial entrepreneur having founded, built and sold seven companies including Sovereigh Assurance, Seniors Money and Partners Life, one of New Zealand's market leaders in both life and medical insurance.  Partners Life was sold in 2022 to Japanese insurer Dai Ichi for in excess of NZ$1B. Richard 

Director

Chief Financial Officer

Richard is a serial entrepreneur having founded, built and sold seven companies including Sovereigh Assurance, Seniors Money and Partners Life, one of New Zealand's market leaders in both life and medical insurance.  Partners Life was sold in 2022 to Japanese insurer Dai Ichi for in excess of NZ$1B. Richard is a significant investor in the healthcare space.  His achievements in business and philanthropy were recognized in the 2024 King's Birthday Honours.

Copyright © 2026 Stir Pharma - All Rights Reserved.

Powered by

  • Our Team
  • INVESTOR CONTACT

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept